Primary Peritoneal Carcinoma Active Not Recruiting Phase 2 Trials for Niraparib (DB11793)

IndicationStatusPhase
DBCOND0028874 (Primary Peritoneal Carcinoma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03326193Phase 2, A Study of Niraparib Combined With Bevacizumab Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based ChemotherapyTreatment